Abstract
An advanced gastric cancer with liver metastasis was treated with the combination MMC, Etoposide and UFT. Etoposide was administered orally at 25-50 mg/day to the gastric cancer patient with liver metastasis. In operative findings, there was no liver and lymphoid node metastasis. The gastric tumor diminished in size and changed its characteristics due to the chemotherapy. In 19 months, no liver nor LN metastasis was observed by CT scan. Presently, the patient feels well and receives outpatient treatment.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Administration, Oral
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Drug Administration Schedule
-
Etoposide / administration & dosage
-
Gastrectomy*
-
Humans
-
Liver Neoplasms / drug therapy
-
Liver Neoplasms / secondary*
-
Lymph Node Excision
-
Male
-
Mitomycin / administration & dosage
-
Remission Induction
-
Stomach Neoplasms / drug therapy*
-
Stomach Neoplasms / pathology
-
Stomach Neoplasms / surgery
-
Tegafur / administration & dosage
-
Uracil / administration & dosage
Substances
-
Tegafur
-
Mitomycin
-
Uracil
-
Etoposide